首页 | 本学科首页   官方微博 | 高级检索  
     


24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients
Authors:van Leeuwen D J  Yee Leland J  Langner Rebecca G
Affiliation:1. Facultad de Ciencias Políticas y Sociología, Universidad Complutense de Madrid, Campus de Somosaguas, s/n, Pozuelo de Alarcón 28223, Spain;2. Escuela Politécnica Superior, Universidad Autónoma de Madrid, Calle Francisco Tomás y Valiente, 11, Madrid 28049, Spain;3. Facultad de Ciencias Económicas y Empresariales, Universidad de Granada, Paseo de Cartuja, 7, Granada 18011, Spain;1. Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;2. Department of Medicine, Weill Cornell Medical College, New York, New York;3. Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York;4. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York;5. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;6. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York;7. Department of Medicine, Weill Cornell Medical College, New York, New York;8. Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands;9. Pediatric Blood and Marrow Transplantation Program, Princes Maxima Center for Pediatric Oncology, Utrecht, The Netherlands
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号